A candidate identification questionnaire for patients with postmenopausal osteoporosis switched from treatment with a daily or weekly bisphosphonate to once-monthly ibandronate

✍ Scribed by Y. Gokce Kutsal; N. Eskiyurt; J. Irdesel; V. Sepici; H. Ugurlu; Y. Kirazli; F. Ardic; M. Korsic; T. Vlak; M. Grlickov; S.M. Temelkova; M. Lazarov; N. Pilipovic; V. Popovic; A. Dimic; B. Kovacev; D. Ruci; A. Tafaj; E. Kucukalic-Selimovic; D. Avdic; H. Seleskovic; S. Pejicic; B. Butun; G. Akyuz; L. Cerrahoglu; O.F. Sendur; P. Yalcin; S. Oncel; M. Saridogan; T. Sarpel; M. Tosun; K. Senel; S. Gursoy; F. Cantürk; H. Demir; B. Miskic; D. Krpan; F. Skreb; S. Grazio; Z. Crncevic-Orlic; F. Ozdener; H. Oncel

• Book ID: 116324680
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 76 KB
• Volume: 48
• Category: Article
• ISSN: 8756-3282
• DOI: 10.1016/j.bone.2011.03.557